This inventor holds 2 USPTO granted patents. Top assignee: Samchully Pharm. Co.,ltd.. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yongin-si, KR (2006)
- Yogin, KR (2007)
Company Filing History:
Years Active: 2006-2007
Title: The Innovative Contributions of Jae-Sung Kang
Introduction
Jae-Sung Kang is a notable inventor based in Yogin, South Korea. He has made significant contributions to the field of chemistry, particularly in the synthesis of important compounds. With a total of 2 patents to his name, his work has implications in various applications, including pharmaceuticals.
Latest Patents
One of Jae-Sung Kang's latest patents is a method for producing 2-deoxy-L-ribose. This invention relates to an economic synthetic method that simplifies the reaction, separation, and purification processes. The method consists of four steps: protection, activation of 3- and 4-OH groups, inversion, and deprotection. By utilizing 2-deoxy-L-ribose, which is abundant in nature and can be easily synthesized from D-glucose, this invention offers a more economical approach to production.
Another significant patent involves aziridine derivatives and their preparation methods. This invention introduces a new aziridine derivative represented by specific chemical formulae. The preparation method allows for various substitutions, making it versatile for different applications in chemical synthesis.
Career Highlights
Jae-Sung Kang is currently employed at Samchully Pharm. Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a focus on practical and cost-effective solutions in chemical synthesis.
Collaborations
He has collaborated with notable coworkers, including Byoung-Chan Jeon and Sang-Dae Lee, who have contributed to his research and development efforts.
Conclusion
Jae-Sung Kang's innovative work in the field of chemistry, particularly through his patents, showcases his commitment to advancing synthetic methods that are both efficient and economically viable. His contributions are valuable to the pharmaceutical industry and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile